News

The project will focus on non-valvular atrial fibrillation (NVAF) and will examine disease prevalence, treatment complications, such as hospital readmissions, as well as the use of evidence-based guidelines.

The randomized double blind trial included a total of 418 patients with treatment naïve BRAF wild-type unresectable Stage III and IV melanoma and they were given either Opdivo

A total of 239 subjects infected with HPV 16 and/or 18 were enrolled at 39 clinical sites across seven European countries including Belgium, Finland, France, Germany, the Netherlands,

The FDA approval is based on results from the Phase III AURELIA trial that showed Avastin plus chemotherapy reduced the risk of disease worsening or death (progression-free survival)

These results will be presented in a poster presentation this evening at 7:30 PM ET at the 19th Annual Scientific Meeting and Education Day of the Society for

Initial results are being presented this weekend to clinicians convening during the American Heart Association meeting held in Chicago, including a meeting of the Association of Black Cardiologists.

The round includes initial angel and strategic investors and new investors Hillhouse Capital and CITIC Capital Partners, as well as an undisclosed blue chip U.S. public investment fund

This online proprietary platform: Emphasizes regulatory compliance of finished products Highlights quality assurance programs to prospective clients Showcases compliance to retailer programs The global economy and increased overseas

Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands PD-L1 and PD-L2. The trial evaluated pembrolizumab at doses of 2mg/kg every three